There are 449 resources available
Current diagnostic standards for NSCLC: Clinical implications
Presenter: Keith Kerr
Session: Advancing molecular diagnosis in lung cancer
Resources:
Slides
Webcast
The fundamental role and updates of systemic therapy in oligometastatic NSCLC
Presenter: Miguel García Pardo de Santayana
Session: Oligometastases: New insights
Resources:
Slides
Webcast
Introduction
Session: YO Clinical cases discussion
Resources:
Webcast
Complete resection in thymic tumors: How far the surgeons may push surgery?
Presenter: Paul van Schil
Session: New frontiers in thymoma
Resources:
Slides
Webcast
Metastasis-directed therapy for oligometastasis: Technological advances and applications
Presenter: Fernando Gomez-Munoz
Session: Oligometastases: New insights
Resources:
Slides
Webcast
Clinical case 1: Advanced Rare mutations - ALK, ROS1, RET, HER2 and BRAF
Presenter: Alessandro Scala
Session: YO Clinical cases discussion
Resources:
Slides
Webcast
Controversies in the histologic definitions of the T component in thymic tumors
Presenter: Anja Roden
Session: New frontiers in thymoma
Resources:
Slides
Webcast
Dilemma and decision: Local consolidative therapy for oligometastasis
Presenter: FengMing Kong
Session: Oligometastases: New insights
Resources:
Slides
Webcast
Expert discussant - Panel discussion
Presenter: Umberto Malapelle
Session: YO Clinical cases discussion
Resources:
Webcast
Immunotherapy (IO) and targeted therapy in thymic tumors: What’s new?
Presenter: Nicolas Girard
Session: New frontiers in thymoma
Resources:
Slides
Webcast